CRINETICS PHARMACEUTIC
59.81
07-十一月-24 14:59:58
15 分钟延时
股票
+0.65
+1.10%
今日范围
58.66 - 60.17
ISIN
N/A
来源
NASDAQ
-
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
20 10月 2021 15:01:37 条件 Nasdaq GlobeNewswire
-
18 10月 2021 15:00:00 条件 Nasdaq GlobeNewswire
-
27 9月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in September Investor Conferences
07 9月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
02 9月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
10 8月 2021 15:02:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces $15.0 Million Private Placement with Frazier Healthcare Partners
29 7月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
28 6月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Garlan Adams as General Counsel
16 6月 2021 07:30:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
06 5月 2021 15:05:02 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Closing of Common Stock Offering
12 4月 2021 15:05:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
07 4月 2021 17:31:23 条件 Nasdaq GlobeNewswire
-
30 3月 2021 15:05:00 条件 Nasdaq GlobeNewswire
-
24 3月 2021 06:10:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Pipeline Progress on Display at ENDO 2021
22 3月 2021 06:10:00 条件 Nasdaq GlobeNewswire
-
12 3月 2021 06:10:00 条件 Nasdaq GlobeNewswire
-
04 2月 2021 06:10:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study
03 2月 2021 06:10:00 条件 Nasdaq GlobeNewswire